Sai Parenterals IPO Update

Key Highlights

• ₹122.6 crore raised from anchor investors ahead of the initial public offering (IPO) of Sai Parenterals.
• 31,28,458 equity shares allocated to anchor investors at ₹392 per share.
• Morgan Stanley (Asia) Singapore Pte, Kotak Mahindra Life Insurance Company, and Kotak Life Sciences Fund 1 among marquee institutions participating in the anchor book.

IPO Details

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

• IPO Opening Date: Tuesday, March 24, 2026
• IPO Closing Date: Friday, March 27, 2026
• Price Band: ₹372-₹392 per share
• IPO Size: Fresh issue of 0.73 crore shares aggregating to ₹285 crore and offer for sale of 0.32 crore shares aggregating to ₹123.79 crore

Allocation

• Qualified Institutional Buyers (QIBs): Not more than 50% of the net offer
• Non-Institutional Investors (NIIs): Not more than 15% of the net offer
• Retail Individual Investors: Not more than 35% of the net offer

Application Details

Read also: Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO

• Lot Size: 38 shares
• Minimum Investment: ₹14,896 (upper price band) for one lot

Proceeds Utilization

• Capacity Expansion and Manufacturing Upgradation: ₹111 crore
• Establishment of New R&D Centre: ₹18 crore
• Debt Repayment: ₹14.30 crore
• General Corporate Purposes: Remaining portion

Timeline

• Allotment Status: Finalized on March 30, 2026
• Tentative Listing Date: April 2, 2026